Delivery Order SPE2DR25D1100-SPE2DR26FCL4D
- Not listed
- The Defense Logistics Agency awarded a $7,760.84 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector units, with an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,399.82 for TALTZ 80 MG/ML AutoInjector on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $3,346.05 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract represents a pediatric delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $17,581.86 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Taltz 80 mg/ml auto-injector medication. This firm fixed-price contract, which is not set-aside, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a $31,833.56 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector (2-pack) pharmaceutical products, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $15,731.15 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,702.09 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector 2-packs on July 15, 2025, with completion targeted for July 16, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and runs through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $12,688.26 to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml auto-injectors, with a firm fixed price structure and an ultimate completion date of May 28, 2025. This non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,493.38 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on October 22, 2025, with an ultimate completion date of October 23, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply to be performed at the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCL4DDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,408.43 for TALTZ 80 MG/ML AutoInjector on October 29, 2025, with an ultimate completion date of October 30, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a leading pharmaceutical distributor supporting federal medical procurement needs. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's medical supply chain, delivering a comprehensive portfolio of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive federal contract awards demonstrate capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. TALTZ (ixekizumab), an injectable biologic used to treat autoimmune conditions, represents part of the company's specialized medical commodity offerings. This delivery order reflects the agency's continued reliance on AmerisourceBergen's pharmaceutical distribution infrastructure to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 10/29/25 |